Super‐responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment

AC van der Heijden, U Höke, J Thijssen… - European journal of …, 2014 - Wiley Online Library
Aims Mortality and ventricular arrhythmias are reduced in patients responding to cardiac
resynchronization therapy (CRT). This response is accompanied by improvement in LVEF …

[PDF][PDF] Super-responders to Cardiac Resynchronization Therapy Remain at Risk for Ventricular Arrhythmias and Benefit from Defibrillator Treatment

AC van der Heijden, U Höke… - Cardioverter …, 2016 - scholarlypublications …
Aims Mortality and ventricular arrhythmias are reduced in patients responding to cardiac
resynchronization therapy (CRT). This response is accompanied by improvement in LVEF …

Super-responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment

AC van der Heijden, U Höke… - … journal of heart …, 2014 - pubmed.ncbi.nlm.nih.gov
Aims Mortality and ventricular arrhythmias are reduced in patients responding to cardiac
resynchronization therapy (CRT). This response is accompanied by improvement in LVEF …

Super-responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment.

AC van der Heijden, U Höke, J Thijssen… - European Journal of …, 2014 - europepmc.org
Aims Mortality and ventricular arrhythmias are reduced in patients responding to cardiac
resynchronization therapy (CRT). This response is accompanied by improvement in LVEF …

[引用][C] Super-responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment

AC van der Heijden, U Hoke… - European …, 2014 - scholarlypublications …
Super-responders to cardiac resynchronization therapy remain at risk for ventricular
arrhythmias and benefit from defibrillator treatment | Scholarly Publications Skip to main content …